Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip B Hylemon

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Hepatology Communications|July 28, 2025
Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGFβ-induced fibroinflammatory mediators in cholangiocytesSayed Obaidullah Aseem, Jing Wang, Maleeha F Kalaiger, et al.
Hepatology Communications|January 8, 2025
Sphingosine kinase 2 (SphK2) depletion alters redox metabolism and enhances inflammation in a diet-induced MASH mouse modelKaitlyn G Jackson, Derrick Zhao, Lianyong Su, et al.
Cell & Bioscience|January 25, 2024
Therapeutic potential of berberine in attenuating cholestatic liver injury: insights from a PSC mouse modelYanyan Wang, Derrick Zhao, Lianyong Su, et al.
Hepatology (Baltimore, Md.)|January 26, 2017
The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in miceYongqing Wang, Hiroaki Aoki, Jing Yang, et al.
Scientific Reports|December 23, 2015
Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes MellitusJasmohan S Bajaj, Naga S Betrapally, Phillip B Hylemon, et al.
Cancer Research|August 16, 2014
AEG-1 regulates retinoid X receptor and inhibits retinoid signalingJyoti Srivastava, Chadia L Robertson, Devaraja Rajasekaran, et al.
Molecular Biosystems|November 21, 2014
A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberineShenghua Gu, Bei Cao, Runbin Sun, et al.
Cell & Bioscience|October 12, 2022
RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expressionYanyan Wang, Yun-Ling Tai, Grayson Way, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 5, 2014
Colonic inflammation and secondary bile acids in alcoholic cirrhosisGenta Kakiyama, Phillip B Hylemon, Huiping Zhou, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal TransplantJasmohan S Bajaj, Genta Kakiyama, Tor Savidge, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Hepatology Communications|July 28, 2025
Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGFβ-induced fibroinflammatory mediators in cholangiocytesSayed Obaidullah Aseem, Jing Wang, Maleeha F Kalaiger, et al.
Hepatology Communications|January 8, 2025
Sphingosine kinase 2 (SphK2) depletion alters redox metabolism and enhances inflammation in a diet-induced MASH mouse modelKaitlyn G Jackson, Derrick Zhao, Lianyong Su, et al.
Cell & Bioscience|January 25, 2024
Therapeutic potential of berberine in attenuating cholestatic liver injury: insights from a PSC mouse modelYanyan Wang, Derrick Zhao, Lianyong Su, et al.
Hepatology (Baltimore, Md.)|January 26, 2017
The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in miceYongqing Wang, Hiroaki Aoki, Jing Yang, et al.
Scientific Reports|December 23, 2015
Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes MellitusJasmohan S Bajaj, Naga S Betrapally, Phillip B Hylemon, et al.
Cancer Research|August 16, 2014
AEG-1 regulates retinoid X receptor and inhibits retinoid signalingJyoti Srivastava, Chadia L Robertson, Devaraja Rajasekaran, et al.
Molecular Biosystems|November 21, 2014
A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberineShenghua Gu, Bei Cao, Runbin Sun, et al.
Cell & Bioscience|October 12, 2022
RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expressionYanyan Wang, Yun-Ling Tai, Grayson Way, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 5, 2014
Colonic inflammation and secondary bile acids in alcoholic cirrhosisGenta Kakiyama, Phillip B Hylemon, Huiping Zhou, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal TransplantJasmohan S Bajaj, Genta Kakiyama, Tor Savidge, et al.
Pageof 13